As a clinical Postdoctoral Researcher in the group of dr FabMarino, you will play a central role in advancing the group's research through the development and application of state-of-the-art immunopeptidomics/proteomics workflows for antigen identification, quantification, and validation. Your work will directly contribute to translational and precision medicine initiatives, with a particular focus on the discovery of clinically relevant targets for cancer immunotherapy. In this role, you will support the team by driving mass spectrometry-based method development and contributing your expertise to a range of proteogenomics and immunology-related projects. Beyond providing technical leadership, you will proactively introduce innovative ideas, establish new research directions, and spearhead initiatives that strengthen the group's scientific capabilities. You will have the opportunity to make a significant impact by developing novel workflows that enable the identification, accurate quantification of antigens and associated mechanisms of T-cell recognition. These discoveries will support the development of next-generation vaccine-based therapies, ultimately contributing to improved outcomes for patients with cancer. 
Finally, you will be involved in many different multicentered and multidisciplinary collaborations, with both industry as well as academia and medical institutes. This will increase your exposure and expand your own professional network supporting your future scientific career.